Prof. Dr. Gisela Degen

Wissenschaftliche Mitarbeiterin

Publikationen

Hier finden Sie die Publikationen ab 2010, die am IfADo entstanden sind.

Ali N, Manirujjaman M, Rana S, Degen GH:

Determination of aflatoxin M1 and deoxynivalenol biomarkers in infants and children urines from Bangladesh. Arch Toxicol 94: 3775–3786 (2020)

Ali N, Degen GH:

Biological monitoring for ochratoxin A and citrinin and their metabolites in urine samples of infants and children in Bangladesh. Mycotoxin Res 36: 409-417 (2020)

Guth S, Hüser S, Roth A, Degen G, Diel P, Edlund K, Eisenbrand G, Engel K-H, Epe B, Grune T, Heinz V, Henle T, Humpf H-U, Jäger H, Joost H-G, Kulling SE, Lampen A, Mally A, Marchan R, Marko D, Mühle E, Nitsche MA, Röhrdanz E, Stadler R, van Thriel C, Vieths S, Vogel RF, Wascher E, Watzl C, Nöthlings U, Hengstler JG:

Toxicity of fluoride: critical evaluation of evidence for human developmental neurotoxicity in epidemiological studies, animal experiments and in vitro analyses. Arch Toxicol 94: 1375-1415 (2020)

Bitsch A, Degen GH, Hillesheim W, Metzler M:

Nachruf Professor Dr. rer. nat. Hans-Günter Neumann, Würzburg. Biospektrum 26: 94-95 (2020)

Ali N, Degen GH:

Biomonitoring of zearalenone and its main metabolites in urines of Bangladeshi adults. Food Chem Toxicol 130: 276–283 (2019)

Malir F, Louda M, Ostry V, Toman J, Ali N, Grosse Y, Malirova E, Pacovsky J, Pickova D, Brodak M, Pfohl-Leszkowicz A, Degen GH:

Analyses of biomarkers of exposure to nephrotoxic mycotoxins in a cohort of patients with renal tumours. Mycotoxin Res 35: 391-403 (2019)

Ali N, Degen GH:

Citrinin biomarkers: a review of recent data and application to human exposure assessment. Arch Toxicol 93: 3057-3066 (2019)

Ali N, Degen GH:

Urinary biomarkers of exposure to the mycoestrogen zearalenone and its modified forms in German adults. Arch Toxicol 92: 2691-2700 (2018)

Degen GH:

Biomarker-based assessment of human exposure to citrinin. In: Max Rubner-Institut, MRI (Hrsg.): Max Rubner Conference 2018 “Fungi and mycotoxins in foods”. Karlsruhe, October 8-10, 2018, Speaker abstracts (p 21). Karlsruhe: MRI, 2018

Braun D, Ezekiel CN, Abia WA, Wisgrill L, Degen GH, Turner PC, Marko D, Warth B:

Monitoring Early Life Mycotoxin Exposures via LC-MS/MS Breast Milk Analysis. Anal Chem 90: 14569-14577 (2018)

Ali N, Hossain K, Degen GH:

Blood plasma biomarkers of citrinin and ochratoxin A exposure in young adults in Bangladesh. Mycotoxin Res 34: 59–67 (2018)

Scientific Committee on Consumer Safety (SCCS), Rousselle C, Degen G [u. a.]:

Opinion of the Scientific Committee on Consumer Safety (SCCS) – Final version of the opinion on decamethylcyclopentasiloxane (cyclopentasiloxane, D5) in cosmetic products. Regul Toxicol Pharmacol 83: 117-118 (2017)

Scientific Committee on Consumer Safety (SCCS), Rousselle C, Degen G [u. a.]:

Opinion of the Scientific Committee on Consumer Safety (SCCS) - Final version of the opinion on vitamin A (retinol, retinyl acetate and retinyl palmitate) in cosmetic products. Regul Toxicol Pharmacol 84: 102-104 (2017)

Solecki R, Kortenkamp A, Bergman Å, Chahoud I, Degen GH, Dietrich D, Greim H, Håkansson H, Hass U, Husoy T, Jacobs M, Jobling S, Mantovani A, Marx-Stoelting P, Piersma A, Ritz V, Slama R, Stahlmann R, van den Berg M, Zoeller RT, Boobis AR:

Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statement. Arch Toxicol 91: 1001-1006 (2017)

Munoz K, Cramer B, Dopstadt J, Humpf H-U, Degen GH:

Evidence of ochratoxin A conjugates in urine samples from infants and adults. Mycotoxin Res 33: 39-47 (2017)